| Factor Information | |
|---|---|
| Data ID | 391 |
| Factor | predicted peak VO2 |
| Description | Peak VO2 averaged predicted was lower than controls on univariable analysis |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Peak VO2 averaged predicted was lower than controls on univariable analysis |
| p Value | 0.004 |
| Conclusion | Peak VO2 averaged only 50.1% ± 13.5% predicted (15.5 ± 5.2 ml/kg/min) and was lower than controls on univariable analysis |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 53 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF |
| Reference | |
|---|---|
| PMID | 30216689 |
| Year | 2018 |
| Title | Exercise testing and spirometry as predictors of mortality in congenital heart disease: Contrasting Fontan physiology with repaired tetralogy of Fallot. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | a retrospective study | |
| Region | Boston, USA | |
| Method | reviewed | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | TOF index cases(Treatment) | TOF control cases(Control) |
| Number | 15 (TOF cases) | 45 (TOF controls) |
| Age | 42.0 ± 15.3 years | 41.6 ± 14.6 years |
| Gender (Male: Female) | 9:6 | 24:21 |
| Marker Level | 50.1±13.5% | 68.5 ± 15.0% |
